Lindbrook Capital’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding DVAX
DTC
TCM
CC
DM
Lindbrook Capital's DVAX Position: Q1 2025 in Review
Lindbrook Capital increased its Dynavax Technologies (DVAX) stake by 0.9% in Q1 2025, buying an estimated $159 and bringing the position to 1,342 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1418.
Lindbrook Capital first reported a position in DVAX in Q1 2020 and has held it in 21 quarters since. 284 funds tracked by Wall St. Rank hold DVAX as of Q1 2025.
- Lindbrook Capital held 1,342 shares of Dynavax Technologies worth $17.4K as of Q1 2025.
- Lindbrook Capital bought 12 Dynavax Technologies shares in Q1 2025, an estimated $159.
- Dynavax Technologies made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1418 holding.
- Lindbrook Capital first reported a position in Dynavax Technologies in Q1 2020 and has held it in 21 quarters since.
- 284 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2025.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.